Regulation of the inducible cyclo‐oxygenase pathway in human cultured airway epithelial (A549) cells by nitric oxide

British Journal of Pharmacology - Tập 121 Số 7 - Trang 1482-1488 - 1997
D. Neil Watkins1, Michael J. Garlepp2,1, Philip J. Thompson1
1The University Department of Medicine, Queen Elizabeth II Medical Centre, Verdun Street, Nedlands, 6009, Western Australia
2The Australian Neuromuscular Research Institute, Queen Elizabeth II Medical Centre, Verdun Street, Nedlands, 6009, Western Australia

Tóm tắt

In airway epithelium, nitric oxide (NO) is synthesized in the setting of inflammation by inducible nitric oxide synthase (iNOS). Although the role of epithelial derived NO in the regulation of human airways is unknown, prostaglandin E2 (PGE2) is recognised as an important inhibitory mediator in human airways. Cyclo‐oxygenase (COX) is the rate limiting enzyme in the production of prostanoids and since inflammatory pathways enhance the expression of an inducible COX (COX‐2), both COX‐2 and iNOS may be co‐expressed in response to an inflammatory stimulus. Although regulation of the COX‐2 pathway by NO has been demonstrated in animal models, its potential importance in human airway epithelium has not been investigated. The effect of endogenous and exogenous NO on the COX‐2 pathway was investigated in the A549 human airway epithelial cell culture model. Activity of the COX‐2 pathway was assessed by PGE2 EIA, and iNOS pathway activity by nitrite assay. A combination cytokine stimulus of interferon gamma (IFNγ) 100 u ml−1, interleukin‐1β (IL‐1β) 1 u ml−1 and lipopolysaccharide (LPS) 10 μg ml−1 induced nitrite formation which could be inhibited by the competitive NOS inhibitor NG‐nitro‐L‐arginine‐methyl‐ester (L‐NAME). IL‐1β alone (1–50 u ml−1) induced PGE2 formation without significant nitrite formation, a response which was inhibited by the COX‐2 specific inhibitor nimesulide. Submaximal stimuli used for further experiments were IFNγ 100 u ml−1, IL‐1β 1 u ml−1 and LPS 10 μg ml−1 to induce both the iNOS and COX‐2 pathways, and IL‐1β 3 u ml−1 to induce COX‐2 without iNOS activity. Cells treated with IFNγ 100 u ml−1, IL‐1β 1 u ml−1 and LPS 10 μg ml−1 for 48 h either alone, or with the addition of L‐NAME (0 to 10−2 M), demonstrated inhibition by L‐NAME of PGE2 (3.61±0.55 to 0.51±0.04 pg/104 cells; P<0.001) and nitrite (34.33±8.07 to 0 pmol/104 cells; P<0.001) production. Restoration of the PGE2 response (0.187±0.053 to 15.46±2.59 pg/104 cells; P<0.001) was observed after treating cells with the same cytokine stimulus and L‐NAME 10−6 M, but with the addition of the NOS substrate L‐arginine (0 to 10−5 M). Cells incubated with IL‐1β 3 u ml−1 for 6 h, either alone or with addition of the NO donor S‐nitroso‐acetyl‐penicillamine (SNAP) (0 to 10−4 M), demonstrated increased PGE2 formation (1.23±0.03 to 2.92±0.19 pg/104 cells; P< 0.05). No increase in PGE2 formation was seen when the experiment was repeated in the presence of the guanylate cyclase inhibitor methylene blue (50 μM). Cells treated with SNAP alone did not demonstrate an increased PGE2 formation. Cells incubated with IL‐1β 3 u ml−1 for 6 h in the presence of dibutyryl cyclic guanylate monophosphate (0 to 10−3 M) also demonstrated an increased PGE2 response (2.56±0.21 to 4.53±0.64 pg/104 cells; P<0.05). These data demonstrate that in a human airway epithelial cell culture system, both exogenous and endogenous NO increase the activity of the COX‐2 pathway in the setting of inflammatory cytokine stimulation, and that this effect is likely to be mediated by guanylate cyclase. This suggests a role for NO in the regulation of human airway inflammation.

Từ khóa


Tài liệu tham khảo

10.1073/pnas.91.21.10089

10.1136/thx.51.2.218

10.1136/thx.51.3.233

10.1164/ajrccm/140.2.449

10.1021/bi00213a002

10.1016/0092-8674(95)90109-4

10.1164/ajrccm.149.2.7508323

10.1016/0003-2697(82)90118-X

10.1073/pnas.92.17.7809

10.1016/S0140-6736(05)80083-2

10.1164/ajrccm/148.6_Pt_1.1474

10.1164/ajrccm/146.1.137

10.1111/j.1365-2222.1994.tb00980.x

10.1016/0014-2999(94)00601-3

10.1165/ajrcmb/9.4.371

10.1002/ijc.2910170110

10.1007/BF01987623

10.1111/j.1476-5381.1994.tb17093.x

10.1056/NEJM199312303292706

10.1016/S0021-9258(17)36703-0

10.1164/ajrccm/148.3.727

Nussler A.K., 1993, Inflammation, immunoregulation and inducible nitric oxide synthase, J. Leukocyte Biol., 54, 171, 10.1002/jlb.54.2.171

O'Neill G.P., 1994, Expression of mRNA for cyclooxygenase 1 and cyclooxygenase 2 in human tissues, FEBS Letts., 330, 156

10.1152/jappl.1987.62.1.219

10.1038/327524a0

10.1016/S0140-6736(95)90409-3

Pradelles P., 1985, Enzyme immunoassay of eicosanoids using acetylcholine esterase as a label: an alternative to radioimmunoassay, Anal. Biochem., 57, 1170

10.1006/bbrc.1994.2169

Rogers J., 1988, Cyclic GMP inhibits protein kinase C mediated secretion in rat pancreatic acini, J. Biol. Chem., 263, 3713, 10.1016/S0021-9258(18)68983-5

10.1172/JCI118035

10.1073/pnas.90.15.7240

10.1172/JCI117185

10.1111/j.1476-5381.1995.tb13330.x

10.1016/0014-2999(94)90047-7

10.1111/j.1476-5381.1995.tb13230.x

Sigal E., 1991, The molecular biology of mammalian arachidonic acid metabolism, Am. J. Physiol., 260, L13

10.1111/j.1476-5381.1995.tb13353.x

10.1172/JCI118641

10.1073/pnas.91.25.12168

10.1183/09031936.95.08010127

10.1006/abbi.1994.1400

10.1073/pnas.91.6.2046

10.1016/0006-2952(77)90182-4

Watkins D.N. Peroni D.J. Basclain K.A. Garlepp M.J.&Thompson P.J.(1997).Expression and activity of nitric oxide synthases in human airway epithelium.Am. J. Respir. Cell Mol. Biol. (in Press).

Thông tin
Thông tin xuất bản

British Journal of Pharmacology

Tập 121 Số 7

1482-1488

Thông tin tác giả